Literature DB >> 18611964

Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years.

Teresa S M Tsang1, Marion E Barnes, Yoko Miyasaka, Stephen S Cha, Kent R Bailey, Grace C Verzosa, James B Seward, Bernard J Gersh.   

Abstract

AIMS: Obesity has been shown to be a risk factor for first atrial fibrillation (AF), but whether it is associated with progression from paroxysmal to permanent AF is unknown. METHODS AND
RESULTS: In this longitudinal cohort study, Olmsted County, MN residents confirmed to have developed paroxysmal AF during 1980-2000 were identified and followed passively to 2006. The interrelationships of body mass index (BMI), left atrial (LA) size, and progression to permanent AF were analysed. Of a total of 3248 patients (mean age 71 +/- 15 years; 54% men) diagnosed with paroxysmal AF, 557 (17%) progressed to permanent AF (unadjusted incidence, 36/1000 person-years) over a median follow-up period of 5.1 years (interquartile range 1.2-9.4). Adjusting for age and sex, BMI independently predicted the progression to permanent AF (hazard ratio, HR 1.04, CI 1.03-1.06; P < 0.0001). Compared with normal BMI (18.5-24.9 kg/m(2)), obesity (30-34.9 kg/m(2)) and severe obesity (>or=35 kg/m(2)) were associated with increased risk for progression [HR 1.54 (CI 1.2-2.0; P = 0.0004) and 1.87 (CI 1.4-2.5; P < 0.0001, respectively)]. BMI remained highly significant even after multiple adjustments. In the subgroup with echocardiographic assessment (n = 744), LA volume was incremental to BMI for independent prediction of progression after multiple adjustments, and did not weaken the association between BMI and progression to permanent AF (HR 1.04; CI 1.02-1.05; P < 0.0001).
CONCLUSION: There was a graded risk relationship between BMI and progression from paroxysmal to permanent AF. This relationship was not weakened by LA volume, which was independent of and incremental to BMI for the prediction of progression to permanent AF.

Entities:  

Mesh:

Year:  2008        PMID: 18611964      PMCID: PMC2733739          DOI: 10.1093/eurheartj/ehn324

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  36 in total

1.  The continuing epidemic of obesity in the United States.

Authors:  A H Mokdad; M K Serdula; W H Dietz; B A Bowman; J S Marks; J P Koplan
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

3.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

Authors:  Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

4.  Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors.

Authors:  L Wilhelmsen; A Rosengren; G Lappas
Journal:  J Intern Med       Date:  2001-11       Impact factor: 8.989

5.  C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.

Authors:  M K Chung; D O Martin; D Sprecher; O Wazni; A Kanderian; C A Carnes; J A Bauer; P J Tchou; M J Niebauer; A Natale; D R Van Wagoner
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

6.  C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation.

Authors:  J Dernellis; M Panaretou
Journal:  Acta Cardiol       Date:  2001-12       Impact factor: 1.718

7.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G De Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

8.  Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation.

Authors:  Cristiana E Juge-Aubry; Emmanuel Somm; Vittorio Giusti; Agnès Pernin; Rachel Chicheportiche; Chantal Verdumo; Françoise Rohner-Jeanrenaud; Danielle Burger; Jean-Michel Dayer; Christoph A Meier
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

9.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

10.  Prevalence and trends in obesity among US adults, 1999-2000.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

View more
  75 in total

1.  Obesity and outcomes among patients with established atrial fibrillation.

Authors:  Afrooz Ardestani; Heather J Hoffman; Howard A Cooper
Journal:  Am J Cardiol       Date:  2010-08-01       Impact factor: 2.778

2.  Obesity begets atrial fibrillation: a contemporary summary.

Authors:  Jared W Magnani; Elaine M Hylek; Caroline M Apovian
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

3.  A novel association of adenosine deaminase with paroxysmal atrial fibrillation: a propensity score analysis from a case-control study.

Authors:  Liang Liu; Yong-Ming He; Cui-Fen Hu; Xin Zhao; Hai-Feng Xu; Xiang-Jun Yang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

4.  Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation.

Authors:  Vincenzo Livio Malavasi; Elisa Fantecchi; Virginia Tordoni; Laura Melara; Andrea Barbieri; Marco Vitolo; Gregory Y H Lip; Giuseppe Boriani
Journal:  Intern Emerg Med       Date:  2020-11-07       Impact factor: 3.397

5.  The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study).

Authors:  Usha B Tedrow; David Conen; Paul M Ridker; Nancy R Cook; Bruce A Koplan; Joann E Manson; Julie E Buring; Christine M Albert
Journal:  J Am Coll Cardiol       Date:  2010-05-25       Impact factor: 24.094

Review 6.  Atrial fibrillation: review of current treatment strategies.

Authors:  Joshua Xu; Jessica G Y Luc; Kevin Phan
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 7.  Obesity Surgery and Anesthesiology Risks: a Review of Key Concepts and Related Physiology.

Authors:  Sjaak Pouwels; Marc P Buise; Pawel Twardowski; Pieter S Stepaniak; Monika Proczko
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

8.  Body mass index and risk of left atrial thrombus in patients with atrial fibrillation.

Authors:  Ri-Bo Tang; Xiao-Hui Liu; Jérôme Kalifa; Zhi-An Li; Jian-Zeng Dong; Ya Yang; Xing-Peng Liu; De-Yong Long; Rong-Hui Yu; Chang-Sheng Ma
Journal:  Am J Cardiol       Date:  2009-12-15       Impact factor: 2.778

9.  Obesity and preclinical changes of cardiac geometry and function.

Authors:  Joong Kyung Sung; Jang-Young Kim
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

10.  Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart.

Authors:  Juan Ybarra; Eugenia Resmini; Francesc Planas; Francesc Navarro-López; Susan Webb; Jose Maria Pou; Alicia Santos; Carlos Ballesta-López
Journal:  Obes Surg       Date:  2009-07-23       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.